1/114
Looks like no tags are added yet.
marijuana is produced from
flowering hemp (Cannabis sativa)
Hemp plants contain over 120 compounds called
phytocannabinoids, with the active compound THC
marijuana
mix of dried leaves and flowering tops; smoked in pipes or bongs or rolled cigarettes ("joints"); sometimes combined with tobacco
THC potency varies, depending on
genetic strain of the plant and growing conditions
THC potency can be increased by
sinsemilla; preventing pollination and seed production
hashish
concentrated form of cannabis - smoked or eaten
dabbing
cannabis is extracted with butane to form a waxy residue with high THC content; a dab (one dose) is vaporized with a blowtorch or vape pen and inhaled
cannabis originated in
China, with medical and religious use traced to ancient China, India, and the Middle East, spreading to the Arab world
Hemp was grown for fiber in colonial America, but marijuana smoking probably came to the U.S
with Mexican and Caribbean immigrants in the early 1900s
In the 1930s, the U.S. Bureau of Narcotics launched a public relations campaign to portray marijuana as
a social menace that can destroy American youth
In 1937, the Marijuana Tax Act instituted a national registration and taxation system aimed at discouraging all use of cannabis
It was overturned in 1969, but marijuana and other forms of cannabis remain regulated by state laws and the federal Controlled Substances Act of 1970.
marijuana routes of admin
can be consumed orally, as in cookies or brownies, but is usually smoked in rolled cigarettes known as "joints," various kinds of pipes, in hollowed-out cigars called "blunts," or mixed with tobacco to form "mulled cigarettes" or "spliffs"
smoked THC is easily
absorbed by the lungs and blood plasma levels rise quickly
THC oral admin
prolonged but poor absorption of THC, resulting in low and variable plasma concentrations due to degradation in the stomach and first pass metabolism
THC metabolites are excreted, with complete elimination occuring
slowly because it persists in fat tissue; THC-COOH detected in urine up to 2 weeks
THC half life in urine
20-30 hours
THC distribution
very lipid soluble and tends to accumulate in fatty tissues in the body. It is slowly leached from fat over time, and therefore, the long-term pharmacological actions are possible
THC accumulation in fat leads to
long rates of elimination, with a half life of 7 days
THC concentrations in plasma begin to decline as a result of
metabolism in the liver and accumulation in the body's fat stores
when THC is metabolized in the liver, its primary metabolite
11-hydroxy-THC is also psychoactive
a cannabinoid receptor in CNS was IDed
in 1988, with receptors occurring in many brain areas
CB1
receptor found in the CNS
CB2
occurs in immune system and found in tissues such as bone, adipose, and GI tract
Cannabinoid receptors are
metabotropic and inhibitory; work via G proteins to inhibit cAMP formation, inhibit voltage-sensitive Ca2+ channels, and open K+ channels.
CB1 receptors are located on
axon terminals - presynaptic
Psychoactive cannabinoids exert their effects by interaction with
the endocannabinoid neurotransmitter system.
Natural Cannabinoids
anandamide and 2AG
the most common endocannabinoid signaling is
retrograde signaling: CB1 receptors on nearby nerve terminals are activated by 2-AG and inhibit Ca2+-mediated neurotransmitter release
non-retrograde cannabinoid signaling
Anandamide remains in the postsynaptic cell and activates either a cannabinoid receptor or a TRPV1 receptor
In the brain, TRPV1 receptors participate in regulating
pain processing, mood, motor function, and learning and memory
neuron-astrocyte signaling
Endocannabinoids activate receptors on nearby astrocytes, resulting in release of glutamate
marijuana is a cannibinoid
partial agonist
cannabis affects memory in lab animals in tests of memory
relies on activation of CB1 receptors in the hippocampus
Interference with memory for spatial tasks involves inhibition of
LTP in the hippocampal CA1 areas
Cannabinoids suppress induction of long-term potentiation in the hippocampus by
inhibiting glutamate neurons
rimonabant
CB1 antagonist; used to treat obesity but have adverse psychiatric side effects
CB1 and CB2 receptors participate in regulating
pain perception and the cognitive-affective responses to pain
Cannabinoids stimulate firing of dopaminergic neurons in the
VTA and enhance DA release in the nucleus accumbens of laboratory animals
CB1 receptors are not expressed by
DA neurons
Cannabinoids activate CB1 receptors in
GABAergic interneurons of the VTA, reducing local GABA release
reducing GABA release releases
dopaminergic neurons from the inhibitory effects of GABA, thus causing increased cell firing
Cannabidiol (CBD)
similar structure to THC; not intoxicating or dependence-producing
CBD can act as a
negative allosteric modulator of CB1 receptors by inhibiting breakdown of endogenous cannabinoids, enhancing activity of the endocannabinoid system
Brain imaging shows THC promotes
regional brain activation and enhanced local blood flow; CBD tends to decrease these processes
Four types of therapeutic cannabinoids
medical, synthetic THC, CBD only extracts, CBD/THC extracts
pure synthetic THC
ronabinol (Marinol), nabilone (Cesamet); enhance appetite or combat nausea
cannabis extracts with CBD and THC
nabiximols (Sativex) neuropathic pain, muscle spasticity in MS
CBD only extracts
Epidiolex reduces seizures in pediatric epilepsy
Medical Marijuana
treats a variety of conditions
Effects of cannabinoid use vary depending on
dose, frequency of use, characteristics of the user, and the setting in which use occurs.
Relaxation is the most commonly reported effect of being "stoned", with sensory reactions including
floating sensations, enhanced visual and auditory perception, visual illusions, and slowing of time passage
Effects of marijuana are at least partially mediated by CB1 receptors
effects are significantly reduced by pretreatment with rimonabant
acute physical effects of marijuana are
increased blood flow to the skin and flushing, increased heart rate, and increased hunger.
Acute cannabis exposure has also been demonstrated to produce
deficits in driving ability, with more pronounced effects occurring when marijuana is combined with alcohol
Endocannabinoids are highly involved in
hunger, eating behavior, & energy metabolism
Multiple brain regions implicated in THC effects on hunger/ feeding behavior
VTA and Nacc - enhanced pleasure from eating
Limbic system - enhanced palatability
Stomach/small intestine - regulates ghrelin
hypothalamus - increased craving/food intake
Smoking marijuana can sometimes produce transient
psychotic symptoms, such as agitation and paranoia
adverse marijuana effects
high doses can cause anxiety, transient psychotic symptoms, paranoia, violent behavior
Acute toxic reaction is manifested as CNS
excitation or depression, tachycardia, and GI symptoms; rarely life-threatening
Marijuana affects a variety of cognitive functions, including
learning, memory, attention, impulse control, and decision making
Animal studies suggest that impairment of hippocampal-dependent learning/memory tasks is related to
cannabinoid effects on the glutamatergic system within this brain area
THC has less reward and reinforcing properties than
opioids in animal tests, with the exception of squirrel monkeys
THC is a partial agonist at the CB1 receptor; WIN55, 212-2
a full agonist at the CB1 receptor, is self-administered by rodents
CB1 receptors are involved in the brain's
reward system and interact with the endogenous opioid systems
Marijuana use typically begins in
adolescence and peaks during young adulthood
If an individual has not yet tried marijuana by his or her mid-twenties
they are unlikely to try it later
The DSM-5 describes a
CUD and cannabis withdrawal syndrome
CUD risk factors
onset of use before age 16, frequency of use, co-use of tobacco, being male - but women tend to have more severe symptoms and progress faster
CUD risk is also influenced by
biological and psychosocial variables including comorbid mood, anxiety, or personality disorders, and the legal status of cannabis availability
regular cannabis users showed tolerance to
the acute intoxicating effects, impairment of cognitive function, feelings of anxiety induced by higher doses, physiological changes such as tachycardia
cannabis tolerance appears to involve a combination of
of desensitization and down-regulation of CB1 receptors
Development of CUD and associated tolerance also includes reduce
glutamate levels in the anterior cingulate cortex and striatum, and impaired striatal dopaminergic function.
Cannabis withdrawal symptoms are similar to
those of nicotine; symptoms can be relieved with smoked or oral THC
what contributes to symptoms of cannabis withdrawal?
Reduced DA cell firing, increased CRF release, and other changes
PET imaging studies have demonstrated widespread decreases in brain
CB1 receptor binding in regular marijuana smokers
CB1 receptor binding recovered following abstinence from
cannabis for a few days
Individuals who had strongest withdrawal symptoms also had lowest levels of
receptor binding
Most cannabis users do not become
dependent or seek treatment
Treatment in outpatient programs involves
cognitive behavioral therapy, relapse prevention training, motivational enhancement therapy, and contingency management (patients vulnerable to relapse)
chronic cannabis use can lead to
adverse behavioral, neurobiological, and health effects, such as impairment in many cognitive domains when assessed following 2 weeks of abstinence
Persistent deficits are most likely to occur if regular, heavy cannabis use begins
in early adolescence
amotivational syndorme
loss of effectiveness and reduced capacity to accomplish goals due to chronic marijuana use
personality characteristics could be a
cause of marijuana use
cannabis brain imaging studies show
lower gray matter volume in some areas - could reflect changes in dendritic arborization and/or synaptic connectivity
rodent studies show that chronic dosing of adolescents with THC or synthetic cannbinoids
results in numerous changes in the glutamatergic, GABAergic, and dopaminergic systems
One rodent study demonstrated deficits in prefrontal dendritic development and
concomitant impairment of synaptic plasticity in the hippocampal-PFC circuitry; contributes to well-known cognitive deficits associated with chronic adolescent cannabis exposure
Several studies have found a significant relationship between early, heavy marijuana smoking and increased risk for
later development of psychotic disorders such as schizophrenia
Smoking marijuana can damage
lungs, and regular smoking is associated with various respiratory symptoms
Marijuana smoking also appears to adversely affect the cardiovascular system
Risk of heart attack is significantly elevated during the hour after smoking marijuana, even in users who are in their 20s or 30s.
cannabis affects reproduction by
producing menstrual cycle irregularities; causes reduced circulating testosterone levels and deficits in sperm concentrations, viability, and motility
Recent studies found a significant association between maternal cannabis use and
Increased risk for maternal anemia, low birth weight, and a greater chance that the newborn will require intensive care.
Synthetic designer cannabinoids (K2 or Spice):
100s synthesized; produced in powdered form that is solubilized and sprayed on herbs or other plants, then smoked or vaporized
synthetic designer cannabinoids activate both
CB1 and CB2 receptors but are more potent than THC; most are full agonists; more likely to cause toxic reactions
opium
dried powdered mixture of 20 alkaloids obtained from the unripe seed capsules of the poppy
opiate
any agent derived from opium
opioid
all substances (exogenous or endogenous) with morphine -like properties
opium poppy
Papaver Somniferum- Originated in Asia/ Middle East
harvesting/producing opium is labor intensive
Opium sap only produced for 10 days of plant's life cycle
Score seedpods
Collect sap
Dry & pound into powder
opium was used as an early method for
pain reduction, first medicinal use reported in 3000 BC
Laudanum
an opium-based medicinal drink, was introduced in 1680 in England.